Which of the following is a potential side effect of Venlafaxine (Effexor)?

Venlafaxine (Effexor) is an antidepressant medication that belongs to the serotonin-norepinephrine reuptake inhibitor (SNRI) class. Common side effects associated with Venlafaxine include gastrointestinal disturbances, especially nausea, but dyslipidemia can also occur, particularly in a subset of individuals.

Dyslipidemia refers to abnormal levels of lipids in the blood, which can lead to cardiovascular issues. Patients taking Venlafaxine may experience changes in lipid profiles, contributing to this potential side effect. While weight loss, rash, and nausea are associated with the medication, they do not directly relate to the significant concern of lipid metabolism that dyslipidemia represents, particularly in long-term use.

Understanding these potential side effects is essential, as they can inform both clinicians and patients in managing treatment plans effectively. Monitoring lipid levels may be advisable for patients on Venlafaxine, helping to mitigate any long-term cardiovascular risks.